U.S. Markets closed

Celgene Corporation (CELG)

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Add to watchlist
134.31+0.63 (+0.47%)
At close: 4:00PM EDT

134.30 -0.01 (-0.01%)
After hours: 7:41PM EDT

People also watch
  • Nice rise in price
  • Stock up 12 pts this week - on what news to warrant this move ?
  • Sold my long term NVDA calls today and bought long term CELG calls. Just think I'll get a little more bang with CELG in the near term.
  • I bought 128 strike June 23 expiration yesterday. Did not think I would get this return. How much longer should I wait before I sell them? Any thoughts?
  • CELG reached a new 52 Week High at 134.18
  • I am hoping that celg cont to run into earning
  • no one is watching celg as it goes up every day hahahaha
  • Wow - up 7.35 - unreal. Lets hold at the close.
  • I wonder if a large company is trying to buy it or if the Insiders know that a stock split is coming. what else could be the reason for this week's strong climb?
  • It may truly be a breakout, but as we saw during the election, it only takes one stupid statement to tank the sector in a heartbeat, that is my concern, have made 33% on it but think I may have to dump at this point. Believe in the stock, but so much political BS determining the values of things right now. Also with low summer volumes, a stock can get pummeled for no good reason by a very small and determined group of investors, sometimes only searching for weak holders of the stock to get a better entry point for large buyers.
  • Breakout after 2 years of consolidation. Very Bullish
  • What do you guys think of the revlimid results?
  • CELG is up 4.90% to 132.41
  • Top secret squirrel stuff that we can't tell you about.
  • CELG reached a new 52 Week High at 128.92
  • bluebird and regeneron are both down preemkt gild is up
  • gawd clueless people
  • we may see 150 in the next two wks
  • (AXSM) Mcap $90 M /Cash $55 M / 5x Phase 3 programs in various indications targeting huge Markets with first results in Q3 2017 =10+ BAGGER ....GLTA !

    Undiscovered and massive undervalued Biotech Stock with lots of Big News on the way.This Stock is brutally undervalued with a Market cap of just $90 million and $55 million in cash .Founder and Ceo is the larget shareholder holding over 7 million shares (30%) more than 50% of O/S is owned by Insider and Institutions which is a great sign .

    This undiscovered stock could be the next 10 bagger gem if just one of their 5 ongoing Phase 3 programs is successful .GL

    Axsome (AXSM)

    Market-Cap: $90 Million
    Cash: $55 Million(cash runway into the first quarter of 2019.)

    Shares Out: 23.5 Million

    Aegis Capital has reiterated a ‘Buy’ rating and price target of $20 on Axsome Therapeutics (NASDAQ: AXSM) after the company reported financial results for the quarter ended March 31, 2017. The analyst noted that although Axsome reported revenue in-line with consensus estimates, the focus remains on upcoming catalysts such as the company’s ongoing clinical trials. Since February 2017, the company’s AXS-05 has received fast track designation from the FDA for the treatment of Alzheimer’s disease (AD) agitation and treatment resistant depression (TRD). Topline data from the TRD treatment study is expected in the first quarter of 2018. Additionally, Axsome is developing AXS-02 in three separate phase 3 clinical programs, including chronic low back pain associated with modic changes and complex regional pain syndrome, with interim data expected in the fourth quarter of 2017, as well as knee osteoarthritis associated with bone marrow lesions, with interim data expected in the third quarter of 2017.
  • well that would be nice 150 by July not likely but yet possible